Skip to content
10-Q

Quarterly Report

BIOTRICITY INC. BTCY

0001493152-26-006211

← back to feed
Filed
Feb 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Feb 11, 2026 28.44M sh
Shares Diluted Q3 2026 · Dec 31, 2025 27.59M sh
Shares Diluted Q3 2026 · Dec 31, 2025 26.88M sh
Dividends Paid Q3 2026 · Dec 31, 2025 $121.95K
Operating Cash Flow Q3 2026 · Dec 31, 2025 −$698.05K
Cash And Equivalents Q3 2026 · Dec 31, 2025 $256.36K
Cash And Equivalents Q3 2026 · Mar 31, 2025 $365.15K
Stockholders Equity Q3 2026 · Dec 31, 2025 −$34.24M
Stockholders Equity Q3 2026 · Sep 30, 2025 −$33.41M
Stockholders Equity Q3 2026 · Mar 31, 2025 −$32.01M
Current Liabilities Q3 2026 · Dec 31, 2025 $23.8M
Current Liabilities Q3 2026 · Mar 31, 2025 $20.64M
Total Liabilities Q3 2026 · Dec 31, 2025 $38.21M
Total Liabilities Q3 2026 · Mar 31, 2025 $35.66M
Current Assets Q3 2026 · Dec 31, 2025 $4.98M
Current Assets Q3 2026 · Mar 31, 2025 $4.64M
Total Assets Q3 2026 · Dec 31, 2025 $5.69M
Total Assets Q3 2026 · Mar 31, 2025 $5.64M
Eps Diluted Q3 2026 · Dec 31, 2025 −$0.04
Eps Diluted Q3 2026 · Dec 31, 2025 −$0.10
Eps Basic Q3 2026 · Dec 31, 2025 −$0.04
Eps Basic Q3 2026 · Dec 31, 2025 −$0.10
Sga Expense Q3 2026 · Dec 31, 2025 $2.19M
Sga Expense Q3 2026 · Dec 31, 2025 $6.63M
Rd Expense Q3 2026 · Dec 31, 2025 $623.57K
Rd Expense Q3 2026 · Dec 31, 2025 $1.92M
Net Income Q3 2026 · Dec 31, 2025 −$717.07K
Net Income Q3 2026 · Dec 31, 2025 −$2.08M
Operating Income Q3 2026 · Dec 31, 2025 $440.92K
Operating Income Q3 2026 · Dec 31, 2025 $996.68K
Gross Profit Q3 2026 · Dec 31, 2025 $3.25M
Gross Profit Q3 2026 · Dec 31, 2025 $9.55M
Cost Of Revenue Q3 2026 · Dec 31, 2025 $736.34K
Cost Of Revenue Q3 2026 · Dec 31, 2025 $2.2M
Revenue Q3 2026 · Dec 31, 2025 $3.99M
Revenue Q3 2026 · Dec 31, 2025 $11.75M
Short Term Debt Q3 2026 · Aug 31, 2025 $1.15M